Mehmet Yavuz is 62 yo. He presented to the clinic and after having an HbA1c test (result 9%) was diagnosed with type 2 Diabetes mellitus.His cardiovascular risk was > 15% http://www.cvdcheck.org.au/His renal health screen showed an eGFR 90 mL/min/1.73m2 with microalbuminuria of 3.5 mg/mmol. http://www.kidney.org.au/HealthProfessionals/DetectingCKD/tabid/632/Default.aspxHe attended a podiatry appointment which detected decreased dorsalis pedis and posterior tibialis pulses in both legs. Management of his condition now includes the following:Exercise: at least 150 minutes of aerobic and 60 minutes of resistance exercise each weekDiet: a plan worked out with an accredited dietician based on the Australian Dietary Guidelines (2013).Drug use: smoking cessation plan to stop cigarette use; alcohol consumption reduction to 1 - 2 full strength beers every second dayWeight loss: Mehmet aims to lose 5 kg over the first 6 - 8 weeks after diagnosisMedications:Jardiamet (empagliflozin 5mg, metformin 500 mg), twice daily, with or after foodramipril 5 mg, dailyRosuzet (rosuvastatin 20mg, ezetimibe 10mg), dailyOngoing diagnostics:HbA1c: every 3 monthslipid profile: every 3 monthsrenal function assessment: annuallypodiatrist assessment: at least once a yearoptometrist assessment: at least once a yearquestion:relate metformin therapy to Mehmet's pathophysiological presentation in brief.

HbA1c level is the average of your glucose levels (sugar) levels over the previous two to three…

Answered: ehmet Yavuz is 62 yo. He presented to…

6th Edition

ISBN:9781451194524

Author:Ruth McCall, Cathee M. Tankersley MT(ASCP)

Publisher:Ruth McCall, Cathee M. Tankersley MT(ASCP)

Chapter1: Phlebotomy: Past And Present And The Healthcare Setting

Section: Chapter Questions

Problem 1SRQ

Related questions

Question

Mehmet Yavuz is 62 yo. He presented to the clinic and after having an HbA1c test (result 9%) was diagnosed with type 2 Diabetes mellitus.

His cardiovascular risk was > 15% http://www.cvdcheck.org.au/

His renal health screen showed an eGFR 90 mL/min/1.73m² with microalbuminuria of 3.5 mg/mmol.

http://www.kidney.org.au/HealthProfessionals/DetectingCKD/tabid/632/Default.aspx

He attended a podiatry appointment which detected decreased dorsalis pedis and posterior tibialis pulses in both legs.

Management of his condition now includes the following:

Exercise: at least 150 minutes of aerobic and 60 minutes of resistance exercise each week
Diet: a plan worked out with an accredited dietician based on the Australian Dietary Guidelines (2013).
Drug use: smoking cessation plan to stop cigarette use; alcohol consumption reduction to 1 - 2 full strength beers every second day
Weight loss: Mehmet aims to lose 5 kg over the first 6 - 8 weeks after diagnosis

Medications:

Jardiamet (empagliflozin 5mg, metformin 500 mg), twice daily, with or after food
ramipril 5 mg, daily
Rosuzet (rosuvastatin 20mg, ezetimibe 10mg), daily

Ongoing diagnostics:

question:

relate metformin therapy to Mehmet's pathophysiological presentation in brief.

Expert Solution

Step by step

Solved in 2 steps

Follow-up Questions

Read through expert solutions to related follow-up questions below.

Follow-up Question

You need to do the following for each medication:

describe the mechanism of ACTION/S
identify the AIM of each therapy for Mehmet
relate each therapy to Mehmet's pathophysiological presentation
refer briefly to any GUIDELINES which support the use of each medication
identify one RISK or special consideration for Mehmet whilst taking each medication
identify what evidence will demonstrate the EFFECTIVENESS of each therapy if you were evaluating care provided to Mehmet

Solution